EMCDDA Best practice portal update (3/2021)

Contingency Management – evidence continues to build-up, time to start talking about implementation? According to the just published EMCDDA European Drug Report cocaine is the second most commonly used illicit drug in Europe and the number of people entering treatment for the first time has risen over the last 5 years. Treatments for cocaine use disorders are limited and no pharmacotherapy has been approved in Europe. Current treatment options rely mainly on psychosocial interventions. 15.04.2021